JPS6027390A - Ｆｒ−９００２１６物質を含有する抗腫瘍剤 - Google Patents

Ｆｒ−９００２１６物質を含有する抗腫瘍剤

Info

Publication number
JPS6027390A
JPS6027390A JP58133506A JP13350683A JPS6027390A JP S6027390 A JPS6027390 A JP S6027390A JP 58133506 A JP58133506 A JP 58133506A JP 13350683 A JP13350683 A JP 13350683A JP S6027390 A JPS6027390 A JP S6027390A
Authority
JP
Japan
Prior art keywords
reaction
substance
culture
soluble
chloroform
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58133506A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0434522B2 (enExample
Inventor
Masakuni Okuhara
奥原　正国
Hirokazu Tanaka
田中　洋和
Hideko Kino
木野　英子
Sumio Kiyotoo
清遠　純夫
Masanobu Kosaka
向阪　正信
Hatsuo Aoki
青木　初夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to JP58133506A priority Critical patent/JPS6027390A/ja
Priority to ZA845372A priority patent/ZA845372B/xx
Priority to PH30984A priority patent/PH20405A/en
Priority to IE1832/84A priority patent/IE57748B1/en
Priority to US06/631,244 priority patent/US4680178A/en
Priority to DK348784A priority patent/DK162631C/da
Priority to DE8484108444T priority patent/DE3484155D1/de
Priority to EP84108444A priority patent/EP0132772B1/en
Priority to AU30853/84A priority patent/AU560728B2/en
Priority to IL72451A priority patent/IL72451A/xx
Publication of JPS6027390A publication Critical patent/JPS6027390A/ja
Publication of JPH0434522B2 publication Critical patent/JPH0434522B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP58133506A 1983-07-21 1983-07-21 Ｆｒ−９００２１６物質を含有する抗腫瘍剤 Granted JPS6027390A (ja)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP58133506A JPS6027390A (ja) 1983-07-21 1983-07-21 Ｆｒ−９００２１６物質を含有する抗腫瘍剤
ZA845372A ZA845372B (en) 1983-07-21 1984-07-11 Antitumor agent
PH30984A PH20405A (en) 1983-07-21 1984-07-13 Anti-tumor agent container fr.900216 substance or its pharmaceutically acceptable salts thereof
IE1832/84A IE57748B1 (en) 1983-07-21 1984-07-16 Fr-900216 substance obtainable by cultivating atcc 20577 for use as an active therapeutic substance and pharmaceutical antitumor composition comprising fr-900216 substance
US06/631,244 US4680178A (en) 1983-07-21 1984-07-16 Antitumor agent comprising FR-900216
DK348784A DK162631C (da) 1983-07-21 1984-07-16 Forbindelse, betegnet fr-900216, til anvendelse som terapeutisk aktivt stof, farmaceutisk praeparat indeholdende forbindelsen samt anvendelse af forbindelsen
DE8484108444T DE3484155D1 (de) 1983-07-21 1984-07-18 Fr-900216-verbindung, durch kultivierung von atcc 20577 gewonnen, als aktive therapeutische verbindung genutzt, und sie enthaltende antitumorale pharmazeutische zusammensetzung von fr-900216.
EP84108444A EP0132772B1 (en) 1983-07-21 1984-07-18 Fr-900216 substance obtainable by cultivating atcc 20577 for use as an active therapeutic substance and pharmaceutical antitumor composition comprising fr-900216 substance
AU30853/84A AU560728B2 (en) 1983-07-21 1984-07-19 Fr-900216 (rhizoxin)
IL72451A IL72451A (en) 1983-07-21 1984-07-19 Pharmaceutical antitumor composition containing rhizoxin and method for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58133506A JPS6027390A (ja) 1983-07-21 1983-07-21 Ｆｒ−９００２１６物質を含有する抗腫瘍剤

Publications (2)

Publication Number Publication Date
JPS6027390A true JPS6027390A (ja) 1985-02-12
JPH0434522B2 JPH0434522B2 (enExample) 1992-06-08

Family

ID=15106361

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58133506A Granted JPS6027390A (ja) 1983-07-21 1983-07-21 Ｆｒ−９００２１６物質を含有する抗腫瘍剤

Country Status (2)

Country Link
JP (1) JPS6027390A (enExample)
ZA (1) ZA845372B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6084220A (ja) * 1983-10-17 1985-05-13 Norin Suisansyo Nogyo Kankyo Gijutsu Kenkyusho 植物病原菌リゾ−プス・キネンシスの代謝産物リゾキシンを有効成分とする抗腫瘍剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6084220A (ja) * 1983-10-17 1985-05-13 Norin Suisansyo Nogyo Kankyo Gijutsu Kenkyusho 植物病原菌リゾ−プス・キネンシスの代謝産物リゾキシンを有効成分とする抗腫瘍剤

Also Published As

Publication number Publication date
ZA845372B (en) 1985-02-27
JPH0434522B2 (enExample) 1992-06-08

Similar Documents

Publication Publication Date Title
KR0135600B1 (ko) 항암 항생물질 mi43-37f11, 그 제조방법 및 그 용도
JPS6016236B2 (ja) 抗生物質ｃ―１５００３ ｐ―３の製造法
JPH04352783A (ja) １２員環マクロライド系化合物
JPS61148189A (ja) Ｃｌ−１５７７ｄおよびｃｌ−１５７７ｅ抗生／抗腫瘍化合物およびそれらの製法
CN107298669A (zh) 源于草酸青霉的黑麦酮酸i及抗人口腔表皮样癌药物应用
JPS6027390A (ja) Ｆｒ−９００２１６物質を含有する抗腫瘍剤
JPH03141290A (ja) 抗腫瘍抗生物質ｂｍｙ―４１３３９
JPS625990A (ja) 抗生物質およびその製造方法
JPH07278041A (ja) 抗腫瘍性物質ｂｅ−２４８１１及びその製造法
JPS6015318B2 (ja) 新抗生物質ｓｆ−１９４２物質，その製造法およびそれを含有する抗ガン剤
JPS6219599A (ja) 新規マクロライド系抗生物質ｍ１１９
JP2594085B2 (ja) 新規抗腫瘍抗生物質ｓｆ２５７５物質ならびにその製造法
JPS61151149A (ja) デイフアラニソ−ルａ及びその製造法
JPS623789A (ja) 抗生物質トキマイシンａおよびその製造法
JPH03279379A (ja) 新規化合物インダノナフトールａおよびｂ
JPS62434A (ja) 新規化合物ｓｓ７３１３ａ及びその製造法並びにこれを含有する免疫調節剤
JPH041179A (ja) 抗腫瘍性物質ｂｅ―１４１０６
JP2000086627A (ja) 抗菌性物質ｂｅ−５４４７６及びその製造法
JPH0259596A (ja) 新規物質、その使用および製造
JPH04108787A (ja) 新規１８員環マクロライド化合物
JPH0314588A (ja) 生理活性物質３８２２ａ，ｂ
JPH02275893A (ja) マクロライド系化合物
JPH0449291A (ja) 生理活性物質ｆｄ―８９１
JPS58319B2 (ja) 新抗生物質ｓｆ−１９１７物質とその製造法
JPS62277378A (ja) カズサマイシンｂ、その製造法およびその用途